The Chk1 inhibitor Prexasertib is effective against in vitro models of aggressive thyroid carcinomas with p53 function defects
收藏官方服务:
资源简介:
This set of raw data cannot be made publicly available as including sensitive information, but might be available to interested researchers upon reasonable requests. Please, forward you request to: v.cirello@auxologico.it
提供机构:
Zenodo创建时间:
2025-05-09



